Story perspectives

Surbhi Sarna's Collate Secures $30M to Revolutionize Life Sciences

1/14/2025

27 4

Summary

Story summary

Surbhi Sarna sold nVision Medical for $275 million and is launching Collate to automate life sciences documentation with AI.
Collate has secured $30 million in seed funding, achieving a valuation exceeding $100 million.
The startup aims to enhance efficiency in paperwork for drug and medical device companies.
Robin AI, founded by Richard Robinson and Dr. James Clough, automates contract reviews to lower legal costs.
In 2024, Robin AI raised $26 million to expand services and improve legal access.

1 of 1

Story summary

Surbhi Sarna sold nVision Medical for $275 million and is launching Collate to automate life sciences documentation with AI.
Collate has secured $30 million in seed funding, achieving a valuation exceeding $100 million.
The startup aims to enhance efficiency in paperwork for drug and medical device companies.
Robin AI, founded by Richard Robinson and Dr. James Clough, automates contract reviews to lower legal costs.
In 2024, Robin AI raised $26 million to expand services and improve legal access.